China301060.CS▼
Lanwei Medical Releases 2026 Interim Report with Net Profit of 63.5938 Million Yuan
Lanwei Medical released its 2026 interim report, with net profit attributable to the parent company of 63.5938 million yuan. The company's total operating revenue was 592 million yuan, down 22.09% from the same period last year, a decrease of 168 million yuan. Net cash inflow from operating activities was 153 million yuan. The latest asset-liability ratio was 23.75%, gross margin was 27.24%, ROE was 4.10%, and diluted earnings per share was 0.16 yuan.